Want to see MTD full AI Analyst Report?
Top Page
Mettler-Toledo
(NYSE:MTD)
Select Model
Select Model
Rating:75Outperform
Price Target:
$1,452.00
▲(3.83% Upside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by strong underlying financial performance (high margins and free-cash-flow strength) and a positive earnings update with raised guidance. Offsetting factors are balance-sheet leverage/negative equity history, stretched technical conditions after a strong run, and a premium valuation (P/E ~31.8) without a stated dividend yield.
Positive Factors
Strong and stable profitability
Mettler-Toledo’s consistently high gross, operating, and net margins indicate differentiated products, service value, and disciplined execution. Stability across recent periods supports durable earnings quality and provides room to fund innovation, productivity initiatives, and customer support while absorbing moderate cost pressure.
Negative Factors
Meaningful leverage and volatile equity base
Meaningful debt combined with a history of negative or very low equity reduces balance-sheet flexibility despite strong earnings and cash generation. It can constrain capital allocation, make equity-based leverage measures volatile, and leave the company less resilient if operating performance weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong and stable profitability
Mettler-Toledo’s consistently high gross, operating, and net margins indicate differentiated products, service value, and disciplined execution. Stability across recent periods supports durable earnings quality and provides room to fund innovation, productivity initiatives, and customer support while absorbing moderate cost pressure.
Read all positive factors
Mettler-Toledo Key Performance Indicators (KPIs)
Any
Revenue By Segment
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Data provided by:
The Fly
The FlyMettler-Toledo (MTD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$25.66B
Dividend YieldN/A
Average Volume (3M)167.77K
Price to Earnings (P/E)29.1
Beta (1Y)0.90
Revenue Growth6.91%
EPS Growth12.43%
CountryUS
Employees16,600
SectorHealthcare
Sector Strength45
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)44.51
Shares Outstanding20,036,558
10 Day Avg. Volume153,292
30 Day Avg. Volume167,768
Financial Highlights & Ratios
PEG Ratio8.96
Price to Book (P/B)-1.22K
Price to Sales (P/S)7.14
P/FCF Ratio33.86
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1,455.83Price Target Upside4.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)47.33
Revenue Forecast (FY)$4.24B
Mettler-Toledo Business Overview & Revenue Model
Company Description
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its do...
How the Company Makes Money
Mettler-Toledo primarily makes money by selling precision measurement and inspection equipment and by providing recurring services that support those installed instruments. Key revenue streams include: (1) Instrument and system sales: revenue from...
Mettler-Toledo Earnings Call Summary
Earnings Call Date:Jul 30, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Positive
The call conveyed a decidedly positive operational and financial picture: revenue growth beat expectations, margins expanded, adjusted EPS rose ~14% and full-year guidance was raised. Strength was broad-based (China, emerging markets, Lab, Industrial automation, services) and driven by pricing, productivity initiatives (Spinnaker) and product innovation. Notable risks and noise included one-time tariff refund accounting that reduced reported sales, timing-related weakness in Product Inspection and certain projects, EU chemical exposure to energy costs, higher transportation costs, and short backlog that increases near-term sensitivity. On balance, management presented confidence in execution and raised guidance, indicating momentum into the second half despite identifiable near-term risks.Positive Updates
Top-Line Growth Outperformed Expectations
Q2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.
Negative Updates
Tariff Refunds Created One-Time Accounting Noise and Reduced Reported Sales
A one-time gross benefit of $52M from IEEPA tariff refunds benefited cost of sales but was partially offset by a $28M refund to customers that reduced reported net sales by ~3%; the company excludes these items from adjusted results.
Read all updates
Q2-2026 Updates
Positive
Negative
Top-Line Growth Outperformed Expectations
Q2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.
Read all positive updates
Company Guidance
The company raised its full‑year 2026 guidance, now calling for local‑currency sales growth of approximately 4%–5% (organic 3%–4%) excluding the one‑time tariff refunds, with adjusted EPS guidance of $47.15–$47.50 (up ~10%–11%, or ~11%–12% excluding currency); at recent spot rates FX is estimated to be a ~1% benefit to sales and a slight headwind to EPS. For Q3 2026 the company expects local‑currency sales growth of ~4% (including ~0.5% from acquisitions) and adjusted EPS of $12.00–$12.15 (up ~8%–9%, or ~9%–10% excluding currency); currency is expected to be neutral to Q3 sales and a ~1% headwind to Q3 EPS. Additional 2026 assumptions: total amortization ~$78M (purchased intangibles ~$28M pretax, ≈$1.07), interest expense ~$67M, other income ~$24M, effective tax rate ~19%, free cash flow ~ $900M (≈6% growth per share), and share repurchases increased to $875M for the year (vs. $825M annualized in H1).Mettler-Toledo Financial Statement Overview
Summary
Income Statement
88
Very Positive
Balance Sheet
52
Neutral
Cash Flow
86
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.13B | 4.03B | 3.87B | 3.79B | 3.92B | 3.72B |
| Gross Profit | 2.45B | 2.32B | 2.25B | 2.17B | 2.24B | 2.11B |
| EBITDA | 1.30B | 1.23B | 1.22B | 1.18B | 1.24B | 1.10B |
| Net Income | 905.61M | 869.19M | 863.14M | 788.78M | 872.50M | 768.99M |
Balance Sheet | ||||||
| Total Assets | 3.67B | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B |
| Cash, Cash Equivalents and Short-Term Investments | 51.38M | 66.89M | 59.36M | 69.81M | 95.97M | 98.56M |
| Total Debt | 2.11B | 2.34B | 2.13B | 2.20B | 2.13B | 1.80B |
| Total Liabilities | 3.66B | 3.74B | 3.37B | 3.51B | 3.47B | 3.16B |
| Stockholders Equity | 12.82M | -23.64M | -126.89M | -149.94M | 24.79M | 171.42M |
Cash Flow | ||||||
| Free Cash Flow | 863.97M | 848.65M | 864.45M | 860.55M | 737.83M | 801.25M |
| Operating Cash Flow | 975.17M | 955.77M | 968.35M | 965.87M | 859.07M | 908.83M |
| Investing Cash Flow | -172.61M | -193.87M | -119.46M | -131.69M | -139.40M | -314.11M |
| Financing Cash Flow | -817.11M | -755.17M | -855.98M | -859.59M | -716.04M | -590.55M |
Mettler-Toledo Technical Analysis
Negative
1398.46
Price Trends
1362.39
Negative
1271.60
Positive
1317.16
Negative
Market Momentum
-19.63
Positive
31.90
Neutral
9.54
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTD, the sentiment is Negative. The current price of 1398.46 is above the 20-day moving average (MA) of 1374.78, above the 50-day MA of 1362.39, and above the 200-day MA of 1317.16, indicating a bearish trend. The MACD of -19.63 indicates Positive momentum. The RSI at 31.90 is Neutral, neither overbought nor oversold. The STOCH value of 9.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTD.
Mettler-Toledo Risk Analysis
Mettler-Toledo disclosed 29 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Mettler-Toledo Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $223.02B | 32.75 | 13.35% | 0.30% | 7.23% | 7.47% | |
75 Outperform | $25.66B | 29.06 | -1199.91% | ― | 6.91% | 12.43% | |
75 Outperform | $40.35B | 28.87 | 20.47% | 0.56% | 8.60% | 19.07% | |
72 Outperform | $140.97B | 35.41 | 7.66% | 0.72% | 4.56% | 19.34% | |
70 Outperform | $30.39B | 38.16 | 31.08% | ― | 4.97% | -31.78% | |
61 Neutral | $39.46B | 101.58 | 1.88% | ― | 52.47% | -63.86% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
MTD
Mettler-Toledo
1,293.52
33.98
2.70%
A
Agilent
146.93
24.67
20.18%
DHR
Danaher
200.14
11.48
6.09%
ILMN
Illumina
206.45
111.33
117.04%
TMO
Thermo Fisher
609.82
132.10
27.65%
WAT
Waters
408.34
112.95
38.24%
Mettler-Toledo Corporate Events
Executive/Board Changes
Mettler-Toledo Appoints Natalia Shuman to Board of Directors
Positive
Aug 3, 2026
On July 30, 2026, Mettler-Toledo’s board appointed Natalia Shuman as an independent director, effective August 3, 2026, and expanded the board from nine to ten members to accommodate her addition. Her director compensation will match that of...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.